<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2010.162</article-id>
<article-id pub-id-type="publisher-id">etm-02-01-0085</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Glial fibrillary acidic protein is one of the key factors underlying neuron-like elongation in PC12 cells</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>SUGAYA-FUKASAWA</surname><given-names>MAKI</given-names></name><xref rid="fn1-etm-02-01-0085" ref-type="fn"><sup>&#x0002A;</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>WATANABE</surname><given-names>TORU</given-names></name><xref rid="fn1-etm-02-01-0085" ref-type="fn"><sup>&#x0002A;</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>TAMURA</surname><given-names>MICHIKO</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>EGASHIRA</surname><given-names>SATSUKI</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>HISATOMI</surname><given-names>HISASHI</given-names></name><xref ref-type="corresp" rid="c1-etm-02-01-0085"/></contrib>
<aff id="af1-etm-02-01-0085">Laboratory of Cellular and Molecular Biochemistry, Department of Materials and Life Science, Seikei Universty, Musashino-shi, Tokyo 180-8633, 
<country>Japan</country></aff></contrib-group>
<author-notes>
<corresp id="c1-etm-02-01-0085">Correspondence to: Professor Hisashi Hisatomi, Laboratory of Cellular and Molecular Biochemistry, Department of Materials and Life Science, Seikei Universty, 3-3-1 Kichijoji, Kita-machi, Musashino-shi, Tokyo 180-8633, Japan, E-mail: <email>hisatomi@st.seikei.ac.jp</email></corresp><fn id="fn1-etm-02-01-0085" fn-type="equal">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<season>January-February</season>
<year>2011</year></pub-date>
<pub-date pub-type="epub">
<day>5</day>
<month>11</month>
<year>2010</year></pub-date>
<volume>2</volume>
<issue>1</issue>
<fpage>85</fpage>
<lpage>87</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>8</month>
<year>2010</year></date>
<date date-type="accepted">
<day>1</day>
<month>11</month>
<year>2010</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2011, Spandidos Publications</copyright-statement>
<copyright-year>2011</copyright-year></permissions>
<abstract>
<p>Nerve growth factor (NGF) normally induces the differentiation of PC12 cells into a neuron-like phenotype. In this study, we found that exposure of PC12 cells to a temperature of 42&#x000B0;C for 24 h significantly decreased NGF-induced neurite elongation. Glial fibrillary acidic protein (GFAP) levels were decreased when PC12 cells were exposed to the heat stress, while PC12 cells overexpressing the gene encoding GFAP showed resistance. Mock-transfected PC12 cells exposed to NGF could be cultured for 72 h at 37&#x000B0;C, whereas GFAP-transfected PC12 cells exposed to NGF could be cultured for over 100 h. Our results suggest that GFAP is necessary for the long-term maintenance of cells with a neuron-like phenotype.</p></abstract>
<kwd-group>
<kwd>anti-apoptosis</kwd>
<kwd>nerve growth factor</kwd>
<kwd>astrocyte</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Glial fibrillary acidic protein (GFAP) is expressed in astrocytes in the central nervous system (CNS) (<xref rid="b1-etm-02-01-0085" ref-type="bibr">1</xref>) and is involved in many cellular functioning processes, such as cell structure and movement, cell communication and the functioning of the blood-brain barrier (<xref rid="b2-etm-02-01-0085" ref-type="bibr">2</xref>,<xref rid="b3-etm-02-01-0085" ref-type="bibr">3</xref>). It was found that the levels of several proteins expressed in astrocytes are altered in an Alzheimer&#x00027;s disease model (<xref rid="b4-etm-02-01-0085" ref-type="bibr">4</xref>,<xref rid="b5-etm-02-01-0085" ref-type="bibr">5</xref>), and cleavage of GFAP may contribute to astrocyte injury and damage in the Alzheimer&#x00027;s disease brain (<xref rid="b6-etm-02-01-0085" ref-type="bibr">6</xref>&#x02013;<xref rid="b8-etm-02-01-0085" ref-type="bibr">8</xref>). GFAP plays an important role in mitosis, directly or indirectly, by adjusting the filament network present in the cell. During mitosis, the amount of phosphorylated GFAP increases and moves to the cleavage furrow (<xref rid="b9-etm-02-01-0085" ref-type="bibr">9</xref>). <italic>In vitro</italic>, astrocytes treated with antisense RNA against GFAP do not form a neuron-like phenotype (<xref rid="b10-etm-02-01-0085" ref-type="bibr">10</xref>). There are multiple disorders associated with inactive GFAP regulation, and mutations in the coding region of the GFAP gene are associated with Alzheimer&#x00027;s disease (<xref rid="b11-etm-02-01-0085" ref-type="bibr">11</xref>). Therefore, GFAP is thought to play crucial roles in the development and differentiation of astrocytes and is believed to be involved in the long-term maintainance of normal CNS myelination (<xref rid="b12-etm-02-01-0085" ref-type="bibr">12</xref>). However, the mechanisms by which GFAP is involved in the development and differentiation of astrocytes are not yet completely understood. To better understand the effect of GFAP expression on neurons, we generated stable PC12 cell lines overexpressing this gene.</p>
<p>The PC12 cell line, which was derived from a pheochromocytoma of the rat adrenal medulla (<xref rid="b13-etm-02-01-0085" ref-type="bibr">13</xref>), is the most common cell line used as neuron-like cells with neuron-like elongation abilities. Maintenance of the neuronal phenotype and survival of differentiated PC12 cells under serum-free conditions require constant nerve growth factor (NGF) exposure. PC12 cells stop dividing and terminally differentiate when treated with NGF. In the present study, PC12 cells with neuron-like elongation underwent apoptosis within 70&#x02013;80 h. However, the PC12 cells overexpressing pGFAP from the plasmid underwent cell death 120 h after NGF exposure. The overexpression of GFAP delayed cell death in the PC12 cells.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Cell culture</title>
<p>The PC12 cell line was purchased from the Japan Health Science Foundation (HSRRB, Osaka, Japan) and maintained in DMEM supplemented with heat-inactivated fetal bovine serum and horse serum. After culture for 48 h, the cells were treated with 1.0 &#x003BC;M NGF (Kyowa, Tokyo, Japan) for 0, 24, 48, 72, 96 or 120 h. All cells were grown in 5&#x00025; CO<sub>2</sub> at 37&#x000B0;C. The temperature was adjusted to 42&#x000B0;C, and cells were observed. Apoptosis was detected by Annexin V and propidium iodide (PI) staining using flow cytometry (Quanta SC, Beckman Coulter, Fullerton, CA, USA).</p></sec>
<sec>
<title>RT real-time PCR analysis</title>
<p>Total RNA was extracted from the PC12 cells using the QuickGene RNA Cultured Cell HC Kit S (Fujifilm, Kanagawa, Japan) following the manufacturer&#x00027;s instructions. The final RNA preparations were resuspended in diethylpyrocarbonate-treated water and quantified by absorbance analysis at 260 nm. cDNA was prepared by incubating DNase-treated total RNA (0.1 &#x003BC;g) with M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA) in the presence of random primers (Invitrogen). The real-time PCR reaction mixture was prepared using a FastStart SYBR Green Master (Roche Diagnostics, Mannheim, Germany). The primer set for amplification of a <italic>GFAP</italic> mRNA was designed according to GenBank NM_017009, using a forward primer at the exon 2 region, 5&#x02032;-CAA GAT GAA ACC AAC CTG AGG CT-3&#x02032;, and a reverse primer at the exon 4 region, 5&#x02032;-GGC TTG GCC ACA TCC ATC T-3&#x02032; (product length 221 bp). The primer set for amplification of a <italic>myelin basic protein</italic> (<italic>MBP</italic>) mRNA was designed according to GenBank M25889, using a forward primer at the exon 4&#x02013;6 region, 5&#x02032;-GGC AAG GAC TCA CAC ACR AGA ACT-3&#x02032;, and a reverse primer at the exon 7&#x02013;8 region, 5&#x02032;-GGG ACA GGC CTC TCC CCT T-3&#x02032; (product length 154 bp). The primer set for amplification of a <italic>class III &#x003B2;-tubulin</italic> mRNA was designed according to GenBank AF459021, using a forward primer at the exon 2 region, 5&#x02032;-ATA GAC CCC AGC GGC AAC TAT GTG-3&#x02032;, and a reverse primer at the exon 3 region, 5&#x02032;-AGG CCT GAA TAG GTG TCC AAA GGC-3&#x02032; (product length 174 bp). The real-time PCR reaction was carried out for 45 cycles (95&#x000B0;C for 20 sec, 60&#x000B0;C for 30 sec and 72&#x000B0;C for 20 sec) using an iCycler iQ&#x02122; Real-Time Detection System (Bio-Rad, Hercules, CA, USA). <italic>GAPDH</italic> cDNA was amplified for normalization (Applied Biosystems, Foster City, CA, USA); mRNA levels are presented as the mRNA copy number per &#x003BC;g total RNA.</p></sec>
<sec>
<title>Overexpression of pGFAP</title>
<p>The gene encoding <italic>GFAP</italic> was subcloned into the mammalian expression vector pTriEX&#x02122;-3 (Merck, San Diego, CA, USA), and the entire sequence was verified by DNA sequencing. For overexpression in PC12 cells, <italic>GFAP</italic> was subcloned from pTriEX&#x02122;-3 vectors into NovaBlue Singles&#x02122; competent cells (Merck). The resultant plasmids were designated as pGFAP. Cells were seeded at a density of 10<sup>6</sup> cells per 10-cm dish and transfected with 8 &#x003BC;g of plasmid DNA using 120 &#x003BC;l of GeneJuice<sup>&#x000AE;</sup> Transfection reagent (Merck) for 2 h at 37&#x000B0;C, after which time the DMEM medium plus 10&#x00025; serum was changed. After 24 h, cells were cultured under serum-free conditions and exposed to NGF stimulation. PC12 cells that were stably transfected with cDNAs encoding GFAP or the empty vector (mock) were grown to confluence in DMEM.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>RT real-time PCR</title>
<p>The levels of <italic>GFAP</italic> mRNA in the culture at 37&#x000B0;C ranged from 10<sup>4.6</sup> to 10<sup>5.5</sup> copies/&#x003BC;g total RNA and were evaluated as the mean &#x000B1; SE (10<sup>5.1</sup>&#x000B1;10<sup>0.4</sup>) copies/&#x003BC;g total RNA. The levels of <italic>GFAP</italic> mRNA in the culture at 42&#x000B0;C ranged from 0.0 to 10<sup>2.1</sup> copies/&#x003BC;g total RNA and were evaluated as the mean &#x000B1; SE (10<sup>1.2</sup>&#x000B1;10<sup>0.9</sup>) copies/&#x003BC;g total RNA; this difference was significant (p&#x0003C;0.01; Student&#x00027;s t-test). The levels of <italic>MBP</italic> mRNA in the culture at 37 and 42&#x000B0;C were 10<sup>3.9</sup>&#x02013;10<sup>4.6</sup> and 10<sup>3.8</sup>&#x02013;10<sup>4.6</sup> copies/&#x003BC;g total RNA, respectively. The levels of <italic>class III &#x003B2;-tubulin</italic> mRNA in the culture at 37 and 42&#x000B0;C were 10<sup>4.7</sup>&#x02013;10<sup>5.6</sup> and 10<sup>4.9</sup>&#x02013;10<sup>5.3</sup> copies/&#x003BC;g total RNA, respectively (<xref rid="f1-etm-02-01-0085" ref-type="fig">Fig. 1</xref>).</p></sec>
<sec>
<title>Cell culture and overexpression of pGFAP</title>
<p>In the mock-transfected PC12 cells exposed to NGF, no apoptosis was induced at 0, 24 or 48 h at 37&#x000B0;C. After 72 h, apoptosis was induced when the cell that expands the neurite was cultured at 37&#x000B0;C (data not shown). Exposure of PC12 cells to a temperature of 42&#x000B0;C for 24 h significantly decreased NGF-induced neuron-like elongation compared to cells cultured at 37&#x000B0;C, while it was possible to maintain the neuron-like elongation at 42&#x000B0;C in the cells with pGFAP overexpression (<xref rid="f2-etm-02-01-0085" ref-type="fig">Fig. 2</xref>). Mock-transfected PC12 cells showed similar features to control PC12 cells when incubated at 42&#x000B0;C. In cells overexpressing pGFAP, neuron-like elongation was maintained in the culture for 120 h (<xref rid="f3-etm-02-01-0085" ref-type="fig">Fig. 3</xref>).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In the present study, GFAP was found to play an important role, directly or indirectly, in the protection of <italic>in vitro</italic> PC12 cultured cells from damage. Unfortunately, apoptosis progresses rapidly and the relation between the level of GFAP and the degree of inhibition of apoptosis is not yet understood. However, it appears that the existence of GFAP inhibited apoptosis in the PC12 cells with neuron-like elongation. Heat stress at a temperature of 42&#x000B0;C caused the PC12 cells to die. Neuron-like elongation was lost in the cultures at 42&#x000B0;C, and these cells underwent apoptosis. Severe stress was found to play a role in the pathogenesis of neurodegenerative diseases, such as Alzheimer&#x00027;s disease. If neuronal cells can be made sufficiently resistant to stress, then the pathogenesis of neuro-degenerative diseases should be slowed or decreased. Our results corroborate those of other researchers who have shown that GFAP is necessary for the long-term maintenance of the normal CNS (<xref rid="b14-etm-02-01-0085" ref-type="bibr">14</xref>&#x02013;<xref rid="b16-etm-02-01-0085" ref-type="bibr">16</xref>).</p>
<p>The mechanism by which GFAP overexpression inhibits the apoptosis of PC12 cells is uncertain. However, we propose that this novel function of GFAP plays an important role in the ability of astrocytes to protect neuronal cells against apoptosis. These data support the concept that GFAP is responsible for many of the progressive astroglial changes that appear after CNS injury and disease. Further evaluation of this and other possible roles of GFAP, as well as the regulation of GFAP expression, are crucially important for the development of new strategies for maintaining homeostasis in the nervous system.</p></sec></body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-etm-02-01-0085"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ED;guez</surname><given-names>JJ</given-names></name><name><surname>Olabarria</surname><given-names>M</given-names></name><name><surname>Chvatal</surname><given-names>A</given-names></name><name><surname>Verkhratsky</surname><given-names>A</given-names></name></person-group><article-title>Astroglia in dementia and Alzheimer&#x00027;s disease</article-title><source>Cell Death Differ</source><volume>16</volume><fpage>378</fpage><lpage>385</lpage><year>2009</year></element-citation></ref>
<ref id="b2-etm-02-01-0085"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bignami</surname><given-names>A</given-names></name><name><surname>Eng</surname><given-names>LF</given-names></name><name><surname>Dahl</surname><given-names>D</given-names></name><name><surname>Uyeda</surname><given-names>CT</given-names></name></person-group><article-title>Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence</article-title><source>Brain Res</source><volume>43</volume><fpage>429</fpage><lpage>435</lpage><year>1972</year></element-citation></ref>
<ref id="b3-etm-02-01-0085"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antanitus</surname><given-names>DS</given-names></name><name><surname>Choi</surname><given-names>BH</given-names></name><name><surname>Lapham</surname><given-names>LW</given-names></name></person-group><article-title>Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein</article-title><source>Brain Res</source><volume>89</volume><fpage>363</fpage><lpage>367</lpage><year>1975</year></element-citation></ref>
<ref id="b4-etm-02-01-0085"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Counts</surname><given-names>SE</given-names></name><name><surname>Mufson</surname><given-names>EJ</given-names></name></person-group><article-title>The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease</article-title><source>J Neuropathol Exp Neurol</source><volume>64</volume><fpage>263</fpage><lpage>272</lpage><year>2005</year></element-citation></ref>
<ref id="b5-etm-02-01-0085"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelopoulos</surname><given-names>P</given-names></name><name><surname>Agouridaki</surname><given-names>H</given-names></name><name><surname>Vaiopoulos</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cytokines in Alzheimer&#x00027;s disease and vascular dementia</article-title><source>Int J Neurosci</source><volume>118</volume><fpage>1659</fpage><lpage>1672</lpage><year>2008</year></element-citation></ref>
<ref id="b6-etm-02-01-0085"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eng</surname><given-names>LF</given-names></name><name><surname>Ghirnikar</surname><given-names>RS</given-names></name></person-group><article-title>GFAP and astrogliosis</article-title><source>Brain Pathol</source><volume>4</volume><fpage>229</fpage><lpage>237</lpage><year>1994</year></element-citation></ref>
<ref id="b7-etm-02-01-0085"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouser</surname><given-names>PE</given-names></name><name><surname>Head</surname><given-names>E</given-names></name><name><surname>Ha</surname><given-names>KH</given-names></name><name><surname>Rohn</surname><given-names>TT</given-names></name></person-group><article-title>Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer&#x00027;s disease brain</article-title><source>Am J Pathol</source><volume>168</volume><fpage>936</fpage><lpage>946</lpage><year>2006</year></element-citation></ref>
<ref id="b8-etm-02-01-0085"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>RA</given-names></name><name><surname>Brenner</surname><given-names>M</given-names></name><name><surname>Goldman</surname><given-names>JE</given-names></name><name><surname>Messing</surname><given-names>A</given-names></name></person-group><article-title>GFAP and its role in Alexander disease</article-title><source>Exp Cell Res</source><volume>313</volume><fpage>2077</fpage><lpage>2087</lpage><year>2007</year></element-citation></ref>
<ref id="b9-etm-02-01-0085"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tardy</surname><given-names>M</given-names></name><name><surname>Fages</surname><given-names>C</given-names></name><name><surname>Le Prince</surname><given-names>G</given-names></name><name><surname>Rolland</surname><given-names>B</given-names></name><name><surname>Nunez</surname><given-names>J</given-names></name></person-group><article-title>Regulation of the glial fibrillary acidic protein (GFAP) and of its encoding mRNA in the developing brain and in cultured astrocytes</article-title><source>Adv Exp Med Biol</source><volume>265</volume><fpage>41</fpage><lpage>52</lpage><year>1990</year></element-citation></ref>
<ref id="b10-etm-02-01-0085"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefran&#x000E7;ois</surname><given-names>T</given-names></name><name><surname>Fages</surname><given-names>C</given-names></name><name><surname>Peschanski</surname><given-names>M</given-names></name><name><surname>Tardy</surname><given-names>M</given-names></name></person-group><article-title>Neuritic outgrowth associated with astroglial phenotypic changes induced by antisense glial fibrillary acidic protein (GFAP) mRNA in injured neuron-astrocyte cocultures</article-title><source>J Neurosci</source><volume>17</volume><fpage>4121</fpage><lpage>4128</lpage><year>1997</year></element-citation></ref>
<ref id="b11-etm-02-01-0085"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>AB</given-names></name><name><surname>Boespflug-Tanguy</surname><given-names>O</given-names></name><etal/></person-group><article-title>Mutations in GFAP encoding glial fibrillary acidic protein are associated with Alexander disease</article-title><source>Nat Genet</source><volume>27</volume><fpage>117</fpage><lpage>120</lpage><year>2001</year></element-citation></ref>
<ref id="b12-etm-02-01-0085"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goss</surname><given-names>JR</given-names></name><name><surname>Finch</surname><given-names>CE</given-names></name><name><surname>Morgan</surname><given-names>DG</given-names></name></person-group><article-title>Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain</article-title><source>Neurobiol Aging</source><volume>12</volume><fpage>165</fpage><lpage>170</lpage><year>1991</year></element-citation></ref>
<ref id="b13-etm-02-01-0085"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greene</surname><given-names>LA</given-names></name><name><surname>Tischler</surname><given-names>AS</given-names></name></person-group><article-title>Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor</article-title><source>Proc Natl Acad Sci USA</source><volume>73</volume><fpage>2424</fpage><lpage>2428</lpage><year>1976</year></element-citation></ref>
<ref id="b14-etm-02-01-0085"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekny</surname><given-names>M</given-names></name><name><surname>Lev&#x000E9;en</surname><given-names>P</given-names></name><name><surname>Pekna</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally</article-title><source>EMBO J</source><volume>14</volume><fpage>1590</fpage><lpage>1598</lpage><year>1995</year></element-citation></ref>
<ref id="b15-etm-02-01-0085"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibuki</surname><given-names>K</given-names></name><name><surname>Gomi</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><etal/></person-group><article-title>Deficient cerebellar long-term depression impaired eyeblink conditioning and normal motor coordination in GFAP mutant mice</article-title><source>Neuron</source><volume>16</volume><fpage>587</fpage><lpage>599</lpage><year>1996</year></element-citation></ref>
<ref id="b16-etm-02-01-0085"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liedtke</surname><given-names>W</given-names></name><name><surname>Edelmann</surname><given-names>W</given-names></name><name><surname>Bieri</surname><given-names>PL</given-names></name><etal/></person-group><article-title>GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination</article-title><source>Neuron</source><volume>17</volume><fpage>607</fpage><lpage>615</lpage><year>1996</year></element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="f1-etm-02-01-0085" position="float">
<label>Figure 1.</label>
<caption>
<p><italic>GFAP</italic>, <italic>MBP</italic> and <italic>class III &#x003B2;-tubulin</italic> mRNA in the PC12 cells exposed to NGF at 37 or 42&#x000B0;C for 24 h. Triplicate RT real-time PCR analyses were performed as described in Materials and methods. As normalization to the <italic>GAPDH</italic> housekeeping gene is unreliable, mRNA expression levels are presented as the mRNA copy number per &#x003BC;g total RNA.</p></caption>
<graphic xlink:href="ETM-02-01-0085-g00.gif"/></fig>
<fig id="f2-etm-02-01-0085" position="float">
<label>Figure 2.</label>
<caption>
<p>(A) Mock-transfected PC12 cells with NGF after 24 h in culture at 37&#x000B0;C. (B) Mock-transfected cells with NGF after 24 h in culture at 42&#x000B0;C. (C) pGFAP-transfected cells with NGF after 24 h in culture at 42&#x000B0;C. The scale bar in each case represents 50 &#x003BC;m.</p></caption>
<graphic xlink:href="ETM-02-01-0085-g01.gif"/></fig>
<fig id="f3-etm-02-01-0085" position="float">
<label>Figure 3.</label>
<caption>
<p>Determination of the transfection efficiency of pGFAP. (A) Mock-transfected PC12 cells with NGF in culture for 24 h at 37&#x000B0;C. (B) pGFAP-transfected cells with NGF in culture for 24 h at 37&#x000B0;C. (C) Mock-transfected cells with NGF in culture for 120 h at 37&#x000B0;C. (D) pGFAP-transfected cells with NGF in culture for 120 h at 37&#x000B0;C. The scale bar in each case represents 50 &#x003BC;m. Representative data from three independent experiments are shown.</p></caption>
<graphic xlink:href="ETM-02-01-0085-g02.gif"/></fig></sec></back></article>
